Executive Vice President, Chief Science Officer and Chief Medical Officer
Mirjam joined Ferring Pharmaceuticals in January 2018 and has held the role of Chief Science Officer and Chief Medical Officer since July 2020. She is responsible for overseeing Ferring´s Research & Development, Real World Evidence, Global Pharmacovigilance and Global Medical Affairs activities.
Mirjam has over 30 years of global experience in a number of roles across research, medical, clinical development and portfolio management, and joined Ferring as Senior Vice President for Global Development. Prior to joining Ferring, Mirjam held senior leadership positions at Solvay Pharmaceuticals, Schering-Plough, Organon, and MSD . Most recently, she was Chief Executive Officer of a newly-formed science park, which focused on pharmaceutical innovation in the Netherlands.
Mirjam is a qualified medical doctor who graduated with honors from Utrecht University in the Netherlands. She has experience in many therapeutic areas including fertility, contraception, menopause, women´s health, osteoporosis, neurology and dermatology.